Dosage and administration
Flush the affected eye as needed, controlling the rate of flow of solution by pressure on the bottle.
Flush the affected eye as needed, controlling the rate of flow of solution by pressure on the bottle.
Drug Facts
Purified water 98.3%
Eyewash
For cleansing the eye to help relieve irritation or burning by removing loose foreign material
For external use only
Stop use and ask a doctor if you experience
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Flush the affected eye as needed, controlling the rate of flow of solution by pressure on the bottle.
boric acid, sodium borate, sodium chloride
Call 888-628-0581
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Water | ACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| Water | ACTIVE MOIETY | 059QF0KO0R | 1 | |
| Boric Acid | INACTIVE INGREDIENT | R57ZHV85D4 | 1 | |
| Sodium Borate | INACTIVE INGREDIENT | 91MBZ8H3QO | 1 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 13985-609 | 13985-609-04 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BORIC ACID | R57ZHV85D4 | IACT |
| SODIUM BORATE | 91MBZ8H3QO | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| WATER | 059QF0KO0R | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / INTRAVENOUS | 6320 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | GEL / OPHTHALMIC | 0.9 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / IONTOPHORESIS | 0.6 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / PERIDURAL | 8.07 mg | ||
| Boric Acid | BORIC ACID | R57ZHV85D4 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 0.53 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | DROPS / OPHTHALMIC | 0.08 %w/w | ||
| Boric Acid | BORIC ACID | R57ZHV85D4 | SUSPENSION/ DROPS / TOPICAL | 0.3 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / TOPICAL | 0.86 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.8 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 2922 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SHAMPOO / TOPICAL | 150 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / EPIDURAL | 648 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRA-ARTERIAL | 1.35 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRABURSAL | 9 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | TABLET, FILM COATED / ORAL | 100 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SUSPENSION / SUBCUTANEOUS | NA | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SUPPOSITORY / RECTAL | 140 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / PARENTERAL | 210 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / OPHTHALMIC | 10 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 226 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | TABLET, CHEWABLE / ORAL | 20 mg | ||
| Sodium Borate | SODIUM BORATE | 91MBZ8H3QO | SUSPENSION/ DROPS / OPHTHALMIC | 0.03 %w/w | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER, DENTIFRICE / DENTAL | 0.03 mg/mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION, CONCENTRATE / SUBCUTANEOUS | 0.86 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRATUMOR | 1.2 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SYSTEM / IONTOPHORESIS | 3.1 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | CREAM / TOPICAL | 0.4 %w/w | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBMUCOSAL | 16 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SYRUP / ORAL | 40 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION/ DROPS / TOPICAL | 0.23 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | TABLET, COATED / ORAL | 54.7 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, EMULSION / INTRAVENOUS | 0.62 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | TABLET, EXTENDED RELEASE / ORAL | 335.1 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRAVITREAL | 6 mg | ||
| Boric Acid | BORIC ACID | R57ZHV85D4 | SUSPENSION / AURICULAR (OTIC) | 0.6 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 1800 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | TABLET, DELAYED RELEASE / ORAL | 97 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / DENTAL | 0.4 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / EPIDURAL | 3535 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 0.68 %w/v | ||
| Sodium Borate | SODIUM BORATE | 91MBZ8H3QO | EMULSION / OPHTHALMIC | 0.11 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRAMUSCULAR | 1486 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRAVESICAL | 351 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SUSPENSION / ENDOTRACHEAL | 46.76 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRAMUSCULAR | 26 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / RESPIRATORY (INHALATION) | 43 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / SUBCUTANEOUS | 0.8 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBARACHNOID | 0.9 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | JELLY / NASAL | NA | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / SOFT TISSUE | 26 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRACARDIAC | 70 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | GEL / TOPICAL | 0.18 %w/w | ||
| Boric Acid | BORIC ACID | R57ZHV85D4 | EMULSION / OPHTHALMIC | 0.3 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRAVENOUS | 28773 mg | ||
| Sodium Borate | SODIUM BORATE | 91MBZ8H3QO | SOLUTION / AURICULAR (OTIC) | 0.3 %w/w | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRATHECAL | 9 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER / RESPIRATORY (INHALATION) | NA | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRAVITREAL | 10 %w/v | ||
| Boric Acid | BORIC ACID | R57ZHV85D4 | SHAMPOO / TOPICAL | 2 %w/w | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | CAPSULE / ORAL | 6 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022305-001 | PUR-WASH | PURIFIED WATER | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N022305-001 | PUR-WASH | 98.3% | SOLUTION / OPHTHALMIC | RLD, RS | 2011-09-01 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 244969aa-7b28-750c-e063-6394a90ad15d | 1fa0cc05-37ce-4d61-8060-fd89a5d449d2 | 2024-10-12 | Warnings | 1fa0cc05-37ce-4d61-8060-fd89a5d449d2 |
Adverse event summaries are temporarily unavailable. Other product information remains available.